glp 1 deal GoodRx struck a with Novo Nordisk to offer lower prices on GLP-1 drugs at over 70,000 US pharmacies., GoodRx's president and CEO says the decision is part of the company's push for broader access The incorporation of probiotics for gut health adds an extra layer of appeal Life after weight-loss drugs

Endocrine Practice , 27(3), 220225

Ready to Book Your Personal Consultation

GLP-1s do, however, seem to have a lower barrier of entry, as 12% of adults have reported using GLP-1s, as compared to the 1% of eligible adults that have received bariatric surgery

GLP-1 treatment may be appropriate if you: Have obesity (BMI 30+) Have a BMI over 27 with weight-related conditions Have type 2 diabetes Struggle with appetite control or food cravings Have tried traditional weight-loss approaches without lasting success Thousands of Alabama residents are choosing medically supervised GLP-1 therapy for sustainable, long-term results